Evidence map›Paper›PMID 28503153›Full record

ArticleFrontiers in physiology2017

Investigating Engineered Ribonucleoprotein Particles to Improve Oral RNAi Delivery in Crop Insect Pests.

François-Xavier Gillet, Rayssa A Garcia, Leonardo L P Macedo, Erika V S Albuquerque, Maria C M Silva, Maria F Grossi-de-Sa

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Challenges of Robust RNAi-Mediated Gene Silencing inInternational journal of molecular sciences · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Stabilized Double-Stranded RNA Strategy Improves Cotton Resistance to CBW (International journal of molecular sciences · 2022
    Article
  16. Advances in nanocarriers to improve the stability of dsRNA in the environment.Frontiers in bioengineering and biotechnology · 2022
    Review
  17. Review
  18. RNAi Crop Protection Advances.International journal of molecular sciences · 2021
    Review
  19. Article
  20. Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.Chembiochem : a European journal of chemical biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

François-Xavier GilletEmbrapa Genetic Resources and BiotechnologyBrasília, Brazil.
Rayssa A GarciaEmbrapa Genetic Resources and BiotechnologyBrasília, Brazil.
Leonardo L P MacedoEmbrapa Genetic Resources and BiotechnologyBrasília, Brazil.
Erika V S AlbuquerqueEmbrapa Genetic Resources and BiotechnologyBrasília, Brazil.
Maria C M SilvaEmbrapa Genetic Resources and BiotechnologyBrasília, Brazil.
Maria F Grossi-de-SaEmbrapa Genetic Resources and BiotechnologyBrasília, Brazil.
Brazilian Agricultural Research Corporation · BRInstituto Federal de Educação, Ciência e Tecnologia de Brasília · BRUniversidade Católica de Brasília · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetically modified (GM) crops producing double-stranded RNAs (dsRNAs) are being investigated largely as an RNA interference (RNAi)-based resistance strategy against crop insect pests. However, limitations of this strategy include the sensitivity of dsRNA to insect gut nucleases and its poor insect cell membrane penetration. Working with the insect pest cotton boll weevil (

Indexed as

dsRNA protectiongut nucleasesinsect pestoral dsRNA deliveryPTD-DRBDRNA interference (RNAi)

Identifiers

PMID28503153
PMCPMC5408074
OpenAlexW2608752814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.